[Genetic analysis of Drosophila melanogaster chromosome 3 neurodegenerative mutants induced with ethyl methanesulfonate].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 19334613)

Published in Genetika on February 01, 2009

Authors

N P Matiĭtsiv, I B Magorivska, O V Shcherbakova, Ia I Chernik, D V Maksimiv

Articles by these authors

[Effect of different colloid volume-replacing solutions on a changed hemostasis system]. Anesteziol Reanimatol (2004) 0.78

[Chemical and pharmaceutical study of triftazin and stelazine]. Farmatsiia (1976) 0.75

[Thromboelastographic characteristics of different infusion therapy regimens in healthy bone marrow donors]. Anesteziol Reanimatol (2009) 0.75

Structure of the O-specific polysaccharide of the bacterium Providencia alcalifaciens O23 containing a novel component: an amide of D-glucuronic acid with N(epsilon)-(1-carboxyethyl)lysine. Biochemistry (Mosc) (1997) 0.75

[Genomic variation of laboratory strains and natural populations of Drosophila melanogaster exposed to X-irradiation]. Genetika (1997) 0.75

[Pharmacologic characteristics of triftazin syrup]. Farmakol Toksikol (1979) 0.75

[Genetic analysis of X-chromosome neurodegenerative mutants of Drosophila melanogaster induced by ethyl methansulfonate and nitrosoethylurea]. Genetika (2004) 0.75

[Chemically induced Drosophila melanogaster mutants with changes in brain structure]. Genetika (2004) 0.75

[Coating tablets with a protective film]. Farmatsiia (1976) 0.75

[Phenoloxidase in the ontogeny of Drosophila melanogaster]. Ontogenez (1990) 0.75

[Dynamics of neurodegenerative processes and lifespan under the action of Cerebral combined with other pharmaceuticals in Drosophila melanogaster mutants]. Eksp Klin Farmakol (2009) 0.75

[Extractive photometric determination of nonachlazine]. Farmatsiia (1976) 0.75

[Incidence of urination disorders and erectile dysfunction after surgical treatment of congenital anorectal defects in children]. Khirurgiia (Mosk) (2000) 0.75

[KRP/telokin differentially regulates filament assembly and phosphorylation of light chains of non-muscle myosin II in fibroblasts]. Biofizika (2006) 0.75

[Enhancement of coagulation caused by transfusion of artificial plasma-replacement solutions]. Ter Arkh (2009) 0.75

[Peptide inhibitors of myosin light chain kinase. Development of peptidase resistant analogues]. Bioorg Khim (2010) 0.75